方法对比

	生活满意度量表 (SWLS)	流行病学研究中心抑郁量表 (CES-D)	医院焦虑抑郁量表 (HADS)
领域	临床心理学	临床心理学	临床心理学
方法族	Process / pipeline	Process / pipeline	Process / pipeline
起源年份	1985	1977	1983
提出者	Ed Diener, Richard A. Emmons, Richard J. Larsen, and Sharon Griffin	Lenore Sawyer Radloff	Andrew S. Zigmond and Richard P. Snaith
类型	Global life satisfaction self-report	Community-based depression assessment	Anxiety and depression screening in medical populations
开创性文献	Diener, E., Emmons, R. A., Larsen, R. J., & Griffin, S. (1985). The Satisfaction with Life Scale. Journal of Personality Assessment, 49(1), 71-75.	Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385-401.	Zigmond, A. S., & Snaith, R. P. (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica, 67(6), 361-370.
别名	SWLS	CES-D, CESD	HADS, HADS-A, HADS-D
相关	5	5	4
摘要	The Satisfaction with Life Scale (SWLS) is a brief, five-item self-report measure of global life satisfaction developed by Diener, Emmons, Larsen, and Griffin in 1985. It assesses the degree to which individuals are satisfied with their lives as a whole, reflecting a cognitive-judgmental component of subjective well-being. The scale has become a cornerstone instrument in well-being research, psychology, gerontology, and quality-of-life assessment across diverse populations.	The Center for Epidemiologic Studies Depression Scale (CES-D) is a 20-item self-report instrument for measuring depressive symptoms in the general population. Developed by Lenore Radloff in 1977, the CES-D was designed for epidemiological research to rapidly identify depression in community samples. It remains a widely used measure in public health, aging research, and longitudinal cohort studies worldwide.	The Hospital Anxiety and Depression Scale (HADS) is a 14-item self-report instrument measuring anxiety and depression symptoms in medically ill populations. Developed by Zigmond and Snaith in 1983, the HADS was specifically designed for hospital and general medical settings where somatic symptoms of medical illness may confound assessment. It remains the standard anxiety-depression measure in medical, oncology, and cardiac populations worldwide.